Medtronic (MDT) FCF Payout Ratio (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | -80.11% |
| Oct 24, 2025 | 27.79% |
| Jul 25, 2025 | 259.42% |
| Apr 25, 2025 | 1.30% |
| Jan 24, 2025 | -73.57% |
| Oct 25, 2024 | -15.98% |
| Jul 26, 2024 | 396.22% |
| Apr 26, 2024 | -9.88% |
| Jan 26, 2024 | -90.61% |
| Oct 27, 2023 | 160.50% |
| Jul 28, 2023 | 305.36% |
| Apr 28, 2023 | -40.28% |
| Jan 27, 2023 | -51.77% |
| Oct 28, 2022 | 9.80% |
| Jul 29, 2022 | 171.95% |
| Apr 29, 2022 | 13.25% |
| Jan 28, 2022 | -21.07% |
| Oct 29, 2021 | -38.91% |
| Jul 30, 2021 | 62.13% |
| Apr 30, 2021 | 45.69% |
| Jan 29, 2021 | -20.62% |
| Oct 30, 2020 | 103.55% |
| Jul 31, 2020 | -2,237.66% |
| Apr 24, 2020 | 90.03% |
| Jan 24, 2020 | -25.07% |
| Oct 25, 2019 | -23.78% |
| Jul 26, 2019 | 56.36% |
| Apr 26, 2019 | 0.06% |
| Jan 25, 2019 | -45.65% |
| Oct 26, 2018 | 46.79% |
| Jul 27, 2018 | -42.64% |
| Apr 27, 2018 | 134.96% |
| Jan 26, 2018 | -62.17% |
| Oct 27, 2017 | -30.89% |
| Jul 28, 2017 | 230.79% |
| Apr 28, 2017 | 22.73% |
| Jan 27, 2017 | -31.90% |
| Oct 28, 2016 | 0.31% |
| Jul 29, 2016 | -10.03% |
| Apr 29, 2016 | 58.70% |
| Jan 29, 2016 | -32.31% |
| Oct 30, 2015 | -44.10% |
| Jul 31, 2015 | 246.17% |
| Apr 24, 2015 | 45.35% |
| Jan 23, 2015 | -50.79% |
| Oct 24, 2014 | -75.73% |